Cargando…
724. LDBIO Toxoplasma Test in the United States and Beyond: Review of the Device’s Performance on U.S. Samples and its Ability to Avoid False Positives
BACKGROUND: Part of an essential “toolbox” to eliminate Toxoplasma gondii infection is prompt recognition of acute infection acquired during gestation, in order to initiate treatment for congenital toxoplasmosis (CT). From conception to one month post-partum, screening seronegative pregnant women mo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644740/ http://dx.doi.org/10.1093/ofid/ofab466.921 |